Helius Medical Tech Q4 2023 GAAP EPS $(1.47) Beats $(3.77) Estimate, Sales $134.000K Miss $246.333K Estimate
Helius Medical Tech Q4 2023 GAAP EPS $(1.47) Beats $(3.77) Estimate, Sales $134.000K Miss $246.333K Estimate
Helius Medical Tech 2023年第四季度GAAP每股收益（1.47）超过预期（3.77 美元），销售额为13.4万美元，低于预期的246.333万美元
Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(1.47) per share which beat the analyst consensus estimate of $(3.77) by 61.01 percent. The company reported quarterly sales of $134.000 thousand which missed the analyst consensus estimate of $246.333 thousand by 45.60 percent. This is a 52.48 percent decrease over sales of $282.000 thousand the same period last year.
Helius Medical Tech（纳斯达克股票代码：HSDT）公布的季度亏损为每股1.47美元，比分析师普遍预期的3.77美元（3.77美元）高出61.01％。该公司公布的季度销售额为13.4万美元，比分析师普遍预期的246,333美元低45.60％。这比去年同期的28.2万美元的销售额下降了52.48％。